Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.

Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.

Women with polycystic ovary syndrome (PCOS) have high circulating androgens, thought to originate from ovaries and adrenals, and frequently suffer from the metabolic syndrome including obesity. However, serum androgens are positively associated with body mass index (BMI) not only in PCOS, but also i...

Detaylı Bibliyografya
Asıl Yazarlar:	Quinkler, M, Sinha, B, Tomlinson, J, Bujalska, I, Stewart, P, Arlt, W
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2004

Benzer Materyaller

Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

11 beta-hydroxysteroid dehydrogenase type 1 in obese children
Yazar:: Wiegand, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes.
Yazar:: Bujalska, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Yazar:: Wiegand, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
Yazar:: Stewart, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
Yazar:: Bujalska, I, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
Yazar:: Bujalska, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
Yazar:: Bujalska, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Structure and function of human 17beta-hydroxysteroid dehydrogenases.
Yazar:: Lukacik, P, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.
Yazar:: Bujalska, I, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Yazar:: Draper, N, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reactions.
Yazar:: Oppermann, U, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Glioblastoma cells express crucial enzymes involved in androgen synthesis: 3β‐hydroxysteroid dehydrogenase, 17‐20α‐hydroxylase, 17β‐hydroxysteroid dehydrogenase and 5α‐reductase
Yazar:: Jose Antonio Mondragón Dr, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus.
Yazar:: Sinclair, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Effects of glucocorticoids on fat mass and the therapeutic potential of targeting II beta-hydroxysteroid dehydrogenase type I in obesity
Yazar:: Tomlinson, J
Baskı/Yayın Bilgisi: (2009)

Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13
Yazar:: Shenping Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Yazar:: Morgan, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Cerebrospinal fluid production - A role for 11 beta-hydroxysteroid dehydrogenase type 1?
Yazar:: Rauz, S, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
Yazar:: Valsamakis, G, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Yazar:: Swali, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Human type 10 17 beta-hydroxysteroid dehydrogenase: molecular modelling and substrate docking.
Yazar:: Nordling, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors.
Yazar:: Korbonits, M, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
Yazar:: Stewart, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
Yazar:: Tomlinson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes.
Yazar:: Morgan, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
Yazar:: Stimson, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
Yazar:: Tomlinson, J
Baskı/Yayın Bilgisi: (2005)

A case of 17-beta-hydroxysteroid dehydrogenase deficiency type 3 in adult endocrinologist practice
Yazar:: N. V. Molashenko, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism
Yazar:: Yoshimichi Takeda, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

A novel genetically-obese rat model with elevated 11beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue
Yazar:: Giridharan Nappan V, ve diğerleri
Baskı/Yayın Bilgisi: (2010-11-01)

Increased central adiposity and decreased subcutaneous adipose tissue 11β‐hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance—A longitudinal cohort study
Yazar:: Crowley, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)